NASDAQ STOCKHOLM WELCOMES CANTARGIA TO FIRST NORTH

Stockholm, March 17, 2015 — Nasdaq (Nasdaq: NDAQ) announces that the trading in Cantargia AB (short name: CANTA) commenced today on First North at Nasdaq Stockholm. Cantargia belongs to the Health Care sector and is the fifteenth company to be admitted to trading on Nasdaq’s Nordic markets* in 2015.

Founded in 2009/2010 Cantargias objective is to develop a new drug that can become an important part of future cancer treatment. The company has selected and applied for a patent for a product candidate. In preclinical studies the antibody has been shown to have two potential mechanisms of action which complement each other. In 2015 Cantargia will carry out further preclinical studies, primarily in solid tumours. The results of these studies will provide guidance for which indications should be the subject of future clinical studies. For more information, please visit www.cantargia.com.  
 

“I am very excited that Cantargia has advanced to become a company listed on Nasdaq First North“, said Göran Forsberg, CEO of Cantargia. “Cantargia’s research has identified a novel approach for treatment of cancer and after a successful IPO we are extremely motivated to advance our development of a potentially very valuable asset to patients suffering from an incurable disease.“ 

 “We welcome Cantargia to First North and to our Nasdaq-family of companies,” said Adam Kostyál, senior vice president and head of European listings at Nasdaq. “We continue to see a strong interest for the public markets within the life science sector and today’s listing underlines that trend.”

Cantargia has appointed Sedermera Fondkomission as Certified Adviser.

*Main markets and First North at Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm.

About First North
First North is regulated as a multilateral trading facility, operated by the different exchanges within Nasdaq Nordic (First North Denmark is regulated as an alternative marketplace). It does not have the legal status as an EU-regulated market. Companies at First North are subject to the rules of First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market”

About Nasdaq
Nasdaq (Nasdaq: NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,500 listed companies with a market value of over $9.1 trillion and more than 10,000 corporate clients. To learn more, visit http://nasdaq.com/ambition or http://business.nasdaq.com.

Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq OMX Copenhagen A/S, Nasdaq OMX Helsinki Ltd., Nasdaq OMX Iceland hf., Nasdaq OMX Riga, AS, Nasdaq OMX Stockholm AB, Nasdaq OMX Tallinn AS, AB Nasdaq OMX Vilnius, Nasdaq OMX Clearing AB, Nasdaq OMX Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius.

Cautionary Note Regarding Forward-Looking Statements

The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.